Literature DB >> 28108632

Contribution of innate immune cells to pathogenesis of severe influenza virus infection.

Suzanne L Cole1, Ling-Pei Ho2.   

Abstract

Influenza A viruses (IAVs) cause respiratory illness of varying severity based on the virus strains, host predisposition and pre-existing immunity. Ultimately, outcome and recovery from infection rely on an effective immune response comprising both innate and adaptive components. The innate immune response provides the first line of defence and is crucial to the outcome of infection. Airway epithelial cells are the first cell type to encounter the virus in the lungs, providing antiviral and chemotactic molecules that shape the ensuing immune response by rapidly recruiting innate effector cells such as NK cells, monocytes and neutrophils. Each cell type has unique mechanisms to combat virus-infected cells and limit viral replication, however their actions may also lead to pathology. This review focuses how innate cells contribute to protection and pathology, and provides evidence for their involvement in immune pathology in IAV infections.
© 2017 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  infection; influenza; innate immunity

Mesh:

Year:  2017        PMID: 28108632     DOI: 10.1042/CS20160484

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  16 in total

1.  PR8 virus harbouring H5N1 NS gene contributed for THP-1 cell tropism.

Authors:  Prem Prasad Lamichhane; Pilaipan Puthavathana
Journal:  Virusdisease       Date:  2018-10-20

Review 2.  How the Respiratory Epithelium Senses and Reacts to Influenza Virus.

Authors:  Kambez H Benam; Laura Denney; Ling-Pei Ho
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

Review 3.  Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?

Authors:  Elena Ortiz-Zapater; Jaime Signes-Costa; Paula Montero; Inés Roger
Journal:  Biomedicines       Date:  2022-06-15

4.  Intranasal Bifidobacterium longum protects against viral-induced lung inflammation and injury in a murine model of lethal influenza infection.

Authors:  David Groeger; Elisa Schiavi; Ray Grant; Magdalena Kurnik-Łucka; David Michalovich; Rick Williamson; Soren Beinke; Barry Kiely; Cezmi A Akdis; Edith M Hessel; Fergus Shanahan; Liam O' Mahony
Journal:  EBioMedicine       Date:  2020-09-11       Impact factor: 8.143

5.  M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza.

Authors:  Suzanne L Cole; Jake Dunning; Wai Ling Kok; Kambez Hajipouran Benam; Adel Benlahrech; Emmanouela Repapi; Fernando O Martinez; Lydia Drumright; Timothy J Powell; Michael Bennett; Ruth Elderfield; Catherine Thomas; Tao Dong; John McCauley; Foo Y Liew; Stephen Taylor; Maria Zambon; Wendy Barclay; Vincenzo Cerundolo; Peter J Openshaw; Andrew J McMichael; Ling-Pei Ho
Journal:  JCI Insight       Date:  2017-04-06

Review 6.  Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.

Authors:  Jian Zheng; Stanley Perlman
Journal:  Curr Opin Virol       Date:  2017-11-21       Impact factor: 7.090

Review 7.  The Future of Influenza Vaccines: A Historical and Clinical Perspective.

Authors:  Nicole M Bouvier
Journal:  Vaccines (Basel)       Date:  2018-08-30

Review 8.  The role of respiratory epithelium in host defence against influenza virus infection.

Authors:  Laura Denney; Ling-Pei Ho
Journal:  Biomed J       Date:  2018-09-10       Impact factor: 4.910

9.  Transcript Profiling Identifies Early Response Genes against FMDV Infection in PK-15 Cells.

Authors:  Tianliang Zhang; Haotai Chen; Linlin Qi; Jie Zhang; Run Wu; Yongguang Zhang; Yuefeng Sun
Journal:  Viruses       Date:  2018-07-11       Impact factor: 5.048

Review 10.  Respiratory Mononuclear Phagocytes in Human Influenza A Virus Infection: Their Role in Immune Protection and As Targets of the Virus.

Authors:  Sindhu Vangeti; Meng Yu; Anna Smed-Sörensen
Journal:  Front Immunol       Date:  2018-07-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.